Completed
Nimotuzumab in Children With HGG
NCT00561873
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +8 more
- Locations
-
- University Bonn, Children's Medical Hospital Bonn, Germany
Clinical trial condition
Neoplasms, Neuroepithelial
Explore clinical trials studying Neoplasms, Neuroepithelial. Study availability and eligibility vary by location and protocol.
2,951 public trials
642 recruiting studies
Neoplasms, Neuroepithelial trial results
NCT00250887
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +8 more
- Locations
-
- University Hospital Zürich Zurich, Canton of Zurich, Switzerland
NCT00135876
- Conditions
- Brain Diseases, Brain Neoplasms, Brain Tumors, +24 more
- Locations
-
- Kellogg Cancer Center - Evanston Northwestern Healthcare Evanston, Illinois, United States
- Henry Ford Hospital Detroit, Michigan, United States
- Huntsman Cancer Institute Salt Lake City, Utah, United States
- The St. George Hospital Kogarah, New South Wales, Australia
NCT00430911
- Conditions
- Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +17 more
- Locations
-
- Hôpital de la Salpêtrière Paris, Île-de-France Region, France
NCT00190723
- Conditions
- Glioma, Malignant Glioma, Neoplasms, +6 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Bethesda, Maryland, United States
Completed
Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas
NCT00074646
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +8 more
- Locations
-
- Neuro Oncology BranchNational Cancer Institute Bethesda, Maryland, United States
NCT00029783
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
- Locations
-
- California Pacific Medical Center Research Institute San Francisco, California, United States
NCT00028158
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +14 more
- Locations
-
Not specified
Active, Not Recruiting
Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma
NCT03528642
- Conditions
- Astrocytoma, Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3, +16 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
Active, Not Recruiting
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT02152982
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +8 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Katmai Oncology Group Anchorage, Alaska, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States